Company Overview of ID Biomedical Corporation of Quebec
ID Biomedical Corporation of Quebec, doing business as GlaxoSmithKline Biologicals, manufactures vaccines. The company was formerly known as Intellivax International, Inc. and changed its name to ID Biomedical Corporation of Quebec in April 2002. The company was incorporated in 1991 and is based in Quebec City, Canada. ID Biomedical Corporation of Quebec operates as a subsidiary of GlaxoSmithKline plc.
2323 du Parc Technologique Boulevard
Quebec City, QC G1P 4R8
Founded in 1991
Key Executives for ID Biomedical Corporation of Quebec
ID Biomedical Corporation of Quebec does not have any Key Executives recorded.
Similar Private Companies By Industry
|1113131 B.C. Ltd.||Americas|
|1127466 B.C. Ltd.||Americas|
|1600978 Ontario Inc.||Americas|
|48North Cannabis Corporation||Americas|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|The Advertising Council, Inc.||United States|
|Tax Management Inc||United States|
|NYC2012, Inc.||United States|
|John F. Kennedy Center For The Performing Arts||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact ID Biomedical Corporation of Quebec, please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.